Genomics & Informatics

Korea Genome Organization (한국유전체학회)
권호 표지
DOI QR코드

DOI QR Code

Network-Based Protein Biomarker Discovery Platforms

  • Kim, Minhyung (Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu Gyeongbuk Institute of Science and Technology) ;
  • Hwang, Daehee (Department of New Biology and Center for Plant Aging Research, Institute for Basic Science, Daegu Gyeongbuk Institute of Science and Technology)
  • Received : 2015.11.25
  • Accepted : 2016.01.07
  • Published : 2016.03.31
Download PDF
⟨ Previous Next ⟩

Abstract

The advances in mass spectrometry-based proteomics technologies have enabled the generation of global proteome data from tissue or body fluid samples collected from a broad spectrum of human diseases. Comparative proteomic analysis of global proteome data identifies and prioritizes the proteins showing altered abundances, called differentially expressed proteins (DEPs), in disease samples, compared to control samples. Protein biomarker candidates that can serve as indicators of disease states are then selected as key molecules among these proteins. Recently, it has been addressed that cellular pathways can provide better indications of disease states than individual molecules and also network analysis of the DEPs enables effective identification of cellular pathways altered in disease conditions and key molecules representing the altered cellular pathways. Accordingly, a number of network-based approaches to identify disease-related pathways and representative molecules of such pathways have been developed. In this review, we summarize analytical platforms for network-based protein biomarker discovery and key components in the platforms.

Keywords

References

  1. Biomarkers Definitions Working Gruop. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001;69:89-95. https://doi.org/10.1067/mcp.2001.113989
  2. Hawkridge AM, Muddiman DC. Mass spectrometry-based biomarker discovery: toward a global proteome index of individuality. Annu Rev Anal Chem (Palo Alto Calif) 2009;2:265-277. https://doi.org/10.1146/annurev.anchem.1.031207.112942
  3. Aebersold R, Anderson L, Caprioli R, Druker B, Hartwell L, Smith R. Perspective: a program to improve protein biomarker discovery for cancer. J Proteome Res 2005;4:1104-1109. https://doi.org/10.1021/pr050027n
  4. Li D, Chan DW. Proteomic cancer biomarkers from discovery to approval: it's worth the effort. Expert Rev Proteomics 2014;11:135-136. https://doi.org/10.1586/14789450.2014.897614
  5. Frantzi M, Bhat A, Latosinska A. Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development. Clin Transl Med 2014;3:7. https://doi.org/10.1186/2001-1326-3-7
  6. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 2002;1:845-867. https://doi.org/10.1074/mcp.R200007-MCP200
  7. Zubarev RA. The challenge of the proteome dynamic range and its implications for in-depth proteomics. Proteomics 2013;13:723-726. https://doi.org/10.1002/pmic.201200451
  8. Wang P, Whiteaker JR, Paulovich AG. The evolving role of mass spectrometry in cancer biomarker discovery. Cancer Biol Ther 2009;8:1083-1094.
  9. Shen J, Wang W, Wu J, Feng B, Chen W, Wang M, et al. Comparative proteomic profiling of human bile reveals SSP411 as a novel biomarker of cholangiocarcinoma. PLoS One 2012;7:e47476. https://doi.org/10.1371/journal.pone.0047476
  10. Chen JH, Ni RZ, Xiao MB, Guo JG, Zhou JW. Comparative proteomic analysis of differentially expressed proteins in human pancreatic cancer tissue. Hepatobiliary Pancreat Dis Int 2009;8:193-200.
  11. Giles RH, van Es JH, Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim Biophys Acta 2003;1653:1-24.
  12. Leiserson MD, Blokh D, Sharan R, Raphael BJ. Simultaneous identification of multiple driver pathways in cancer. PLoS Comput Biol 2013;9:e1003054. https://doi.org/10.1371/journal.pcbi.1003054
  13. Moore RA, Faris R, Priola SA. Proteomics applications in prion biology and structure. Expert Rev Proteomics 2015;12:171-184. https://doi.org/10.1586/14789450.2015.1019481
  14. Aitman TJ, Boone C, Churchill GA, Hengartner MO, Mackay TF, Stemple DL. The future of model organisms in human disease research. Nat Rev Genet 2011;12:575-582. https://doi.org/10.1038/nrg3047
  15. Baranzini SE. The genetics of autoimmune diseases: a networked perspective. Curr Opin Immunol 2009;21:596-605. https://doi.org/10.1016/j.coi.2009.09.014
  16. Ding Y, Chen M, Liu Z, Ding D, Ye Y, Zhang M, et al. atBioNet: an integrated network analysis tool for genomics and biomarker discovery. BMC Genomics 2012;13:325. https://doi.org/10.1186/1471-2164-13-325
  17. Chuang HY, Lee E, Liu YT, Lee D, Ideker T. Network-based classification of breast cancer metastasis. Mol Syst Biol 2007;3:140.
  18. Baker ES, Liu T, Petyuk VA, Burnum-Johnson KE, Ibrahim YM, Anderson GA, et al. Mass spectrometry for translational proteomics: progress and clinical implications. Genome Med 2012;4:63. https://doi.org/10.1186/gm364
  19. Eng JK, McCormack AL, Yates JR. An approach to correlate tandem mass spectral data of peptides with amino acid sequences in a protein database. J Am Soc Mass Spectrom 1994;5:976-989. https://doi.org/10.1016/1044-0305(94)80016-2
  20. Kim S, Gupta N, Pevzner PA. Spectral probabilities and generating functions of tandem mass spectra: a strike against decoy databases. J Proteome Res 2008;7:3354-3363. https://doi.org/10.1021/pr8001244
  21. Polaskova V, Kapur A, Khan A, Molloy MP, Baker MS. High-abundance protein depletion: comparison of methods for human plasma biomarker discovery. Electrophoresis 2010;31:471-482. https://doi.org/10.1002/elps.200900286
  22. Nesvizhskii AI, Keller A, Kolker E, Aebersold R. A statistical model for identifying proteins by tandem mass spectrometry. Anal Chem 2003;75:4646-4658. https://doi.org/10.1021/ac0341261
  23. Keller A, Nesvizhskii AI, Kolker E, Aebersold R. Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem 2002;74:5383-5392. https://doi.org/10.1021/ac025747h
  24. Elias JE, Gygi SP. Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry. Nat Methods 2007;4:207-214. https://doi.org/10.1038/nmeth1019
  25. Kaji H, Saito H, Yamauchi Y, Shinkawa T, Taoka M, Hirabayashi J, et al. Lectin affinity capture, isotope-coded tagging and mass spectrometry to identify N-linked glycoproteins. Nat Biotechnol 2003;21:667-672. https://doi.org/10.1038/nbt829
  26. Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, et al. Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell 2011;44:325-340. https://doi.org/10.1016/j.molcel.2011.08.025
  27. Carapito C, Lane L, Benama M, Opsomer A, Mouton-Barbosa E, Garrigues L, et al. Computational and Mass-Spectrometry-Based Workflow for the Discovery and Validation of Missing Human Proteins: Application to Chromosomes 2 and 14. J Proteome Res 2015;14:3621-3634. https://doi.org/10.1021/pr5010345
  28. Gygi SP, Rist B, Gerber SA, Turecek F, Gelb MH, Aebersold R. Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat Biotechnol 1999;17:994-999. https://doi.org/10.1038/13690
  29. Ross PL, Huang YN, Marchese JN, Williamson B, Parker K, Hattan S, et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol Cell Proteomics 2004;3:1154-1169. https://doi.org/10.1074/mcp.M400129-MCP200
  30. Thompson A, Schafer J, Kuhn K, Kienle S, Schwarz J, Schmidt G, et al. Tandem mass tags: a novel quantification strategy for comparative analysis of complex protein mixtures by MS/MS. Anal Chem 2003;75:1895-1904. https://doi.org/10.1021/ac0262560
  31. Zhang Y, Fonslow BR, Shan B, Baek MC, Yates JR 3rd. Protein analysis by shotgun/bottom-up proteomics. Chem Rev 2013;113:2343-2394. https://doi.org/10.1021/cr3003533
  32. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat Biotechnol 2008;26:1367-1372. https://doi.org/10.1038/nbt.1511
  33. Dost B, Bandeira N, Li X, Shen Z, Briggs SP, Bafna V. Accurate mass spectrometry based protein quantification via shared peptides. J Comput Biol 2012;19:337-348. https://doi.org/10.1089/cmb.2009.0267
  34. Barallobre-Barreiro J, Didangelos A, Schoendube FA, Drozdov I, Yin X, Fernandez-Caggiano M, et al. Proteomics analysis of cardiac extracellular matrix remodeling in a porcine model of ischemia/reperfusion injury. Circulation 2012;125:789-802. https://doi.org/10.1161/CIRCULATIONAHA.111.056952
  35. Hwang D, Smith JJ, Leslie DM, Weston AD, Rust AG, Ramsey S, et al. A data integration methodology for systems biology: experimental verification. Proc Natl Acad Sci U S A 2005;102:17302-17307. https://doi.org/10.1073/pnas.0508649102
  36. Hwang D, Rust AG, Ramsey S, Smith JJ, Leslie DM, Weston AD, et al. A data integration methodology for systems biology. Proc Natl Acad Sci U S A 2005;102:17296-17301. https://doi.org/10.1073/pnas.0508647102
  37. Tsai CF, Hsu CC, Hung JN, Wang YT, Choong WK, Zeng MY, et al. Sequential phosphoproteomic enrichment through complementary metal-directed immobilized metal ion affinity chromatography. Anal Chem 2014;86:685-693. https://doi.org/10.1021/ac4031175
  38. Huang DW, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009;4:44-57. https://doi.org/10.1038/nprot.2008.211
  39. Mi H, Lazareva-Ulitsky B, Loo R, Kejariwal A, Vandergriff J, Rabkin S, et al. The PANTHER database of protein families, subfamilies, functions and pathways. Nucleic Acids Res 2005;33:D284-D288. https://doi.org/10.1093/nar/gki418
  40. Ekins S, Nikolsky Y, Bugrim A, Kirillov E, Nikolskaya T. Pathway mapping tools for analysis of high content data. Methods Mol Biol 2007;356:319-350.
  41. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-15550. https://doi.org/10.1073/pnas.0506580102
  42. Beck HC, Nielsen EC, Matthiesen R, Jensen LH, Sehested M, Finn P, et al. Quantitative proteomic analysis of post-translational modifications of human histones. Mol Cell Proteomics 2006;5:1314-1325. https://doi.org/10.1074/mcp.M600007-MCP200
  43. Xu G, Paige JS, Jaffrey SR. Global analysis of lysine ubiquitination by ubiquitin remnant immunoaffinity profiling. Nat Biotechnol 2010;28:868-873. https://doi.org/10.1038/nbt.1654
  44. Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, et al. Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 2004;32:D497-D501. https://doi.org/10.1093/nar/gkh070
  45. Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M. BioGRID: a general repository for interaction datasets. Nucleic Acids Res 2006;34:D535-D539. https://doi.org/10.1093/nar/gkj109
  46. Bader GD, Betel D, Hogue CW. BIND: the Biomolecular Interaction Network Database. Nucleic Acids Res 2003;31:248-250. https://doi.org/10.1093/nar/gkg056
  47. Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015;43:D447-D452. https://doi.org/10.1093/nar/gku1003
  48. Chatr-aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, et al. MINT: the Molecular INTeraction database. Nucleic Acids Res 2007;35:D572-D574. https://doi.org/10.1093/nar/gkl950
  49. Severin J, Waterhouse AM, Kawaji H, Lassmann T, van Nimwegen E, Balwierz PJ, et al. FANTOM4 EdgeExpressDB: an integrated database of promoters, genes, microRNAs, expression dynamics and regulatory interactions. Genome Biol 2009;10:R39. https://doi.org/10.1186/gb-2009-10-4-r39
  50. Jiang C, Xuan Z, Zhao F, Zhang MQ. TRED: a transcriptional regulatory element database, new entries and other development. Nucleic Acids Res 2007;35:D137-D140. https://doi.org/10.1093/nar/gkl1041
  51. Feist P, Hummon AB. Proteomic challenges: sample preparation techniques for microgram-quantity protein analysis from biological samples. Int J Mol Sci 2015;16:3537-3563. https://doi.org/10.3390/ijms16023537
  52. Kanehisa M, Goto S, Sato Y, Furumichi M, Tanabe M. KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res 2012;40:D109-D114. https://doi.org/10.1093/nar/gkr988
  53. Ideker T, Ozier O, Schwikowski B, Siegel AF. Discovering regulatory and signalling circuits in molecular interaction networks. Bioinformatics 2002;18 Suppl 1:S233-S240. https://doi.org/10.1093/bioinformatics/18.suppl_1.S233
  54. Lan A, Smoly IY, Rapaport G, Lindquist S, Fraenkel E, Yeger-Lotem E. ResponseNet: revealing signaling and regulatory networks linking genetic and transcriptomic screening data. Nucleic Acids Res 2011;39:W424-W429. https://doi.org/10.1093/nar/gkr359
  55. Komurov K, Dursun S, Erdin S, Ram PT. NetWalker: a contextual network analysis tool for functional genomics. BMC Genomics 2012;13:282. https://doi.org/10.1186/1471-2164-13-282
  56. Morris JH, Apeltsin L, Newman AM, Baumbach J, Wittkop T, Su G, et al. clusterMaker: a multi-algorithm clustering plugin for Cytoscape. BMC Bioinformatics 2011;12:436. https://doi.org/10.1186/1471-2105-12-436
  57. Mitra K, Carvunis AR, Ramesh SK, Ideker T. Integrative approaches for finding modular structure in biological networks. Nat Rev Genet 2013;14:719-732. https://doi.org/10.1038/nrg3552
  58. Wang J, Zuo Y, Man YG, Avital I, Stojadinovic A, Liu M, et al. Pathway and network approaches for identification of cancer signature markers from omics data. J Cancer 2015;6:54-65. https://doi.org/10.7150/jca.10631
  59. Wang J, Zhang Y, Marian C, Ressom HW. Identification of aberrant pathways and network activities from high-throughput data. Brief Bioinform 2012;13:406-419. https://doi.org/10.1093/bib/bbs001
  60. Oishi N, Kumar MR, Roessler S, Ji J, Forgues M, Budhu A, et al. Transcriptomic profiling reveals hepatic stem-like gene signatures and interplay of miR-200c and epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma. Hepatology 2012;56:1792-1803. https://doi.org/10.1002/hep.25890
  61. Hyung SW, Lee MY, Yu JH, Shin B, Jung HJ, Park JM, et al. A serum protein profile predictive of the resistance to neoadjuvant chemotherapy in advanced breast cancers. Mol Cell Proteomics 2011;10:M111.011023. https://doi.org/10.1074/mcp.M111.011023
  62. Vandin F, Upfal E, Raphael BJ. Algorithms for detecting significantly mutated pathways in cancer. J Comput Biol 2011;18:507-522. https://doi.org/10.1089/cmb.2010.0265
  63. Huang SS, Fraenkel E. Integrating proteomic, transcriptional, and interactome data reveals hidden components of signaling and regulatory networks. Sci Signal 2009;2:ra40.
  64. Shi Z, Wang J, Zhang B. NetGestalt: integrating multidimensional omics data over biological networks. Nat Methods 2013;10:597-598. https://doi.org/10.1038/nmeth.2517
  65. Zhu J, Shi Z, Wang J, Zhang B. Empowering biologists with multi-omics data: colorectal cancer as a paradigm. Bioinformatics 2015;31:1436-1443. https://doi.org/10.1093/bioinformatics/btu834
  66. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008;3:e3740. https://doi.org/10.1371/journal.pone.0003740
  67. Cancer Genome Atlas Research Network. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-615. https://doi.org/10.1038/nature10166
  68. Na S, Bandeira N, Paek E. Fast multi-blind modification search through tandem mass spectrometry. Mol Cell Proteomics 2012;11:M111.010199. https://doi.org/10.1074/mcp.M111.010199